tirzepatide class of medication New Blockbuster Type 2 Mounjaro Gets FDA Approval Switching Semaglutide to Tirzepatide: A

Oral GLP-1 is not yet launched in the UK

Maryann Amirshahi, co-medical director of the National Capital Poison Center in Washington, D.C., confirmed that there has been a large overall increase in semaglutide overdoses reported to poison centers nationally

Older age should not be an obstacle to treatment of individuals with established or high risk for CVD

Currently, these drugs must be injected into the thigh, waist, or upper arm once a week

But Wegovy and Ozempic present a particularly difficult case

Recommended Schedule: Weeks 14: 2.5 mg once weekly (starting dose to minimize side effects) Weeks 58: 5 mg once weekly Weeks 912: 7.5 mg once weekly (if well-tolerated) Weeks 1316: 10 mg once weekly (based on response) Weeks 1720: 12.5 mg once weekly (as needed) Week 21+ (Maintenance): Up to 15 mg once weekly All dosage increases should be approved and guided by your prescribing provider